Ozempic among ‘bogus’ drug patents being challenged by U.S. to spur competition – National
Federal regulators are challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic, in the latest effort by the Biden administration targeting pharmaceutical industry practices that drive up …
